Top Suppliers:I want be here

77-19-0

77-19-0 structure
77-19-0 structure
  • Name: dicycloverine
  • Chemical Name: dicyclomine
  • CAS Number: 77-19-0
  • Molecular Formula: C19H35NO2
  • Molecular Weight: 309.48700
  • Catalog: Signaling Pathways Anti-infection Bacterial
  • Create Date: 2016-11-14 11:12:13
  • Modify Date: 2024-01-07 06:14:45
  • Dicyclomine (Dicycloverine) is a potent and orally active muscarinic cholinergic receptors antagonist. Dicyclomine (Dicycloverine) shows high affinity for muscarinic M1 receptor subtype (Ki=5.1 nM) and M2 receptor subtype (Ki=54.6 nM) in brush-border membrane and basal plasma membranes, respectively[1]. Dicyclomine is an antispasmodic agent and relieves smooth muscle spasm of the gastrointestinal tract in vivo[2].

Name dicyclomine
Synonyms Dicyclohexylhydroxyphenylstannane
[1,1'-bicyclohexyl]-1-carboxylic acid 2-(diethylamino)ethyl ester
Stannane,dicyclohexylhydroxyphenyl
dicycloverine
Dicyclohexylphenyltin hydroxide
Bicyclohexyl-1-carbonsaeure-(2-diaethylamino-aethylester)
bicyclohexyl-1-carboxylic acid-(2-diethylamino-ethyl ester)
Dicyclomine
Description Dicyclomine (Dicycloverine) is a potent and orally active muscarinic cholinergic receptors antagonist. Dicyclomine (Dicycloverine) shows high affinity for muscarinic M1 receptor subtype (Ki=5.1 nM) and M2 receptor subtype (Ki=54.6 nM) in brush-border membrane and basal plasma membranes, respectively[1]. Dicyclomine is an antispasmodic agent and relieves smooth muscle spasm of the gastrointestinal tract in vivo[2].
Related Catalog
In Vivo Dicyclomine (Dicycloverine) (intraperitoneal injection; 8 mg/kg; daily) exacerbates the cognitive impairments in all the measurements. In addition, the memory impairments are worse in dicyclomine-treated 3xTg-AD mice compared to dicyclomine-treated NonTg mice[2]. Dicyclomine (Dicycloverine) (intraperitoneal injection; 2.0, 4.0, and 8.0 mg/kg; 7 days) produces a highly significant effect on performance in the paired-associates learning (PAL) task in mice.And systemic treatment at lower doses show behavioral impairments in mice in spatial tasks[3]. Animal Model: C57Bl/6 mice[1] Dosage: 2.0, 4.0, and 8.0 mg/kg Administration: Intraperitoneal injection; daily; 7 days Result: Produced impairments due to actions of the agent outside of the hippocampus.
References

[1]. Antonella Caccamo, et al.  M1 Receptors Play a Central Role in Modulating AD-like Pathology in Transgenic Mice. 2006 Mar 2;49(5):671-82.doi: 10.1016/j.neuron.2006.01.020.

[2]. Antonella Caccamo, et al.  M1 Receptors Play a Central Role in Modulating AD-like Pathology in Transgenic Mice. 2006 Mar 2;49(5):671-82.doi: 10.1016/j.neuron.2006.01.020.

[3]. Susan J Bartko,et al. A Computer-Automated Touchscreen Paired-Associates Learning (PAL) Task for Mice: Impairments Following Administration of Scopolamine or Dicyclomine and Improvements Following Donepezil.Psychopharmacology (Berl). 2011 Mar;214(2):537-48.

Molecular Formula C19H35NO2
Molecular Weight 309.48700
Exact Mass 309.26700
PSA 29.54000
LogP 4.40220

~%

77-19-0 structure

77-19-0

Literature: Tilford; Van Campen; Shelton Journal of the American Chemical Society, 1947 , vol. 69, p. 2902,2904

~%

77-19-0 structure

77-19-0

Literature: Yoshida; Iwashige Pharmaceutical Bulletin, 1955 , vol. 3, p. 417,420

~%

77-19-0 structure

77-19-0

Literature: Verrier Bulletin de la Societe Chimique de France, 1959 , p. 1863

~%

77-19-0 structure

77-19-0

Literature: Kopp; Tchoubar Bulletin de la Societe Chimique de France, 1952 , p. 84

~%

77-19-0 structure

77-19-0

Literature: Kopp; Tchoubar Bulletin de la Societe Chimique de France, 1952 , p. 84